Novartis Investigative Site

Pozuelo de Alarcón/Madrid 28223

0 studies enrolling now · 2 studies all time

What they study most

Thrombocytopaenia

Studies at this site

• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) — Stopped early
• A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia — Completed